📅 PUBMED DAILY TRIAGE — 2026-10-26 Window: 2026-10-25T09:00:00Z → 2026-10-26T09:00:00Z (CRDT) Topics scanned: 10 | Articles reviewed: 104 | Candidates evaluated: 113 High priority: 3 | Standard: 41 | Low/archive: 0 | Unsolicited finds: 4 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
T1: Hematologic malignancies: No high-priority finds today (best retained candidate scored 7/10).
T2: CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best retained candidate scored 5/10).
T3: Early cancer detection: No high-priority finds today (best retained candidate scored 7/10).
T4: AI/ML in clinical diagnostics and imaging: No high-priority finds today (best retained candidate scored 7/10).
T5: Precision oncology and genomic medicine: No high-priority finds today (best retained candidate scored 6/10).
T6: Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID:42927856 · Pembrolizumab plus lenvatinib with belzutifan or quavonlimab as first-line therapy for advanced renal-cell carcinoma: randomized open-label phase 3 LITESPARK-012 study. · 9/10 · Neither addition of the HIF-2α inhibitor belzutifan nor the CTLA-4 inhibitor quavonlimab to pembrolizumab plus lenvatinib improved outcomes in participants with previously untreated advanced RCC versus pembrolizumab and lenvatinib alone. PMID:42927858 · Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial. · 8/10 · These durable responses indicate the potential to eliminate the need for current SOC and redefine the curative-intent treatment paradigm with dostarlimab in dMMR/MSI-H LARC.
T7: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID:42926911 · Concordance Between Trial Efficacy and Real-World Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis. · 8/10 · Real-world mortality associations with SGLT2 inhibitors in HFrEF are directionally concordant with trial efficacy, but their larger magnitude most plausibly reflects residual confounding, including co-prescription of other guideline-directed therapy.
T8: Aging, longevity, and population health: No high-priority finds today (best retained candidate scored 7/10).
T9: Rare diseases with high unmet need: No high-priority finds today (best retained candidate scored 7/10).
🟢⚪ STANDARD (5-7) — Top by Topic
T1: Hematologic malignancies
PMID:42927328 · Adjuvant olaparib for patients with germline BRCA-mutated, high-risk, HER2-negative early breast cancer: real-world data from a French early access program. · 7/10 · Treatment Innovation PMID:42927525 · Predictors of in-hospital venous thromboembolism in patients undergoing primary total hip arthroplasty. · 6/10 · Treatment Innovation PMID:42928032 · Transformed mycosis fungoides: Biological heterogeneity, clinicopathological features, and prognostic determinants. · 5/10 · Treatment Innovation PMID:42928031 · The blind spots of post-transplant AML relapse: from clinical signal to mechanism-matched therapy. · 5/10 · Treatment Innovation PMID:42928030 · Artificial intelligence in myeloproliferative neoplasms: From digital bone marrow pathology to clinical decision support. · 5/10 · Treatment Innovation
T2: CBC-based diagnostics and machine learning in hematology
PMID:42928030 · Artificial intelligence in myeloproliferative neoplasms: From digital bone marrow pathology to clinical decision support. · 5/10 · Treatment Innovation
T3: Early cancer detection
PMID:42927884 · ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2. · 7/10 · Early Detection PMID:42927515 · Leveraging claims data-based small-area estimation to evaluate endoscopy access and the area-level prevalence of being up-to-date with colorectal cancer screening among screen-eligible adults in North Carolina. · 6/10 · Early Detection PMID:42926932 · Baseline prevalence of lung cancer screening and associated factors among women in breast cancer screening clinics prior to the Pink & Pearl program: A retrospective analysis of electronic health records. · 6/10 · Early Detection PMID:42926883 · Age- and sex-specific smoking trends by birth cohort in Norway, 1978-2024: an analysis of cross-sectional survey data. · 6/10 · Early Detection PMID:42926850 · Planner-Executor Style Multimodal Agentic System to Answer Patient Questions in Lung Cancer Screening CT. · 6/10 · Early Detection
T4: AI/ML in clinical diagnostics and imaging
PMID:42927271 · AI-powered optical coherence tomography shows similar performance to intravascular ultrasound for plaque burden quantification: head-to-head benchmark study against histopathology of native coronary arteries. · 7/10 · Diagnostics PMID:42927257 · CardioCLIP: sequential multimodal prediction of echocardiographic abnormalities and natriuretic peptide elevation from electrocardiogram and chest radiographs. · 7/10 · Diagnostics PMID:42927843 · Ultra-early diagnosis recently developments of acute myocardial infarction: Emerging biomarkers and advanced sensing technologies. · 6/10 · Diagnostics PMID:42927276 · Artificial Intelligence for Automated Continuous Quantification of Left Ventricular Ejection Fraction From Standard Adult Transthoracic Echocardiography: A Systematic Review. · 6/10 · Diagnostics PMID:42927086 · Rising spillover risk: Lessons from the Andes hantavirus outbreak. · 6/10 · Diagnostics
T5: Precision oncology and genomic medicine
PMID:42927317 · Beyond PD-L1 and HER2: emerging predictive biomarkers in gastroesophageal tumors. · 6/10 · Genomics/Precision Medicine PMID:42927220 · Core needle biopsy-derived breast cancer microtumors enable functional drug-response testing for precision oncology. · 6/10 · Genomics/Precision Medicine PMID:42926727 · Unlocking the Regulatory Genome by ARGUS: An Evidence-Constrained Agentic Framework for Interpreting Single Nucleotide Variants. · 6/10 · Genomics/Precision Medicine PMID:42928003 · [Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreatic Solid Tumors]. · 5/10 · Genomics/Precision Medicine PMID:42927974 · [Evolution of later-line treatment strategies for advanced colorectal cancer: seeking balance between survival benefit and quality of life]. · 5/10 · Early Detection
T6: Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID:42927317 · Beyond PD-L1 and HER2: emerging predictive biomarkers in gastroesophageal tumors. · 6/10 · Genomics/Precision Medicine PMID:42927974 · [Evolution of later-line treatment strategies for advanced colorectal cancer: seeking balance between survival benefit and quality of life]. · 5/10 · Early Detection PMID:42927201 · Genome-wide CRISPRa screens identify modulators of CAR T survival across diverse tumor cytokine milieus. · 5/10 · Treatment Innovation PMID:42926297 · Assessing the Antitumor Immune Effects of Gut Microbiota in a Preclinical Melanoma Model. · 5/10 · Treatment Innovation
T7: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID:42927970 · [Efficacy and safety of GLP-1 receptor agonists combined with bariatric surgery for obesity: a timing-stratified systematic review]. · 7/10 · Prevention PMID:42927657 · Same Class, Different Risk? Dapagliflozin versus Empagliflozin and Genitourinary Safety in Heart Failure with Preserved Ejection Fraction: A Retrospective Comparative Cohort Study. · 6/10 · Prevention PMID:42927088 · Relative handgrip strength and cardiometabolic multimorbidity among chinese middle-aged and older adults: mediation by metabolic and inflammatory pathways. · 6/10 · Prevention PMID:42926209 · Exploratory clinical predictors and internally validated models of in-hospital mortality after PCI in obese patients with acute myocardial infarction and documented cardiogenic shock: a single-center retrospective study. · 6/10 · Prevention PMID:42927564 · Outcome-specific associations of remnant cholesterol with myocardial infarction and stroke across traditional risk factor burden. · 5/10 · Prevention
T8: Aging, longevity, and population health
PMID:42927958 · [Expert consensus on testosterone supplementation to alleviate aging-related symptoms in men (2026 edition)]. · 7/10 · Public Health PMID:42927467 · Does the Exercise Delay Age-Related Cognitive Impairment: Conversation Between White Matter, Myelin Sheath, and Oligodendrocyte During Exercise? · 6/10 · Public Health PMID:42927019 · THE KIDNEY AS A WINDOW INTO MAMMALIAN AGING: METABOLIC FRAILTY, MITOCHONDRIAL RESILIENCE, AND THE CONTINUUM FROM INJURY TO AGING. · 6/10 · Public Health PMID:42927919 · Treadmill or Overground? Cognitive-Motor Interference Effects in Healthy Older Individuals. · 5/10 · Public Health PMID:42927890 · Factors Associated with Regional Disparities in Advanced Pharmacy Services in Japan. · 5/10 · Public Health
T9: Rare diseases with high unmet need
PMID:42926780 · Overcoming a diagnostic blindspot: Identifying balanced translocations in Mendelian rare disease cohorts. · 7/10 · Diagnostics PMID:42926617 · Systematic evaluation of incomplete penetrance in 4,325 rare disease families reveals divergent transcriptional networks in CHD8 pathology. · 7/10 · Diagnostics PMID:42927875 · Fatal Neonatal mTORopathy: Expanding the Phenotypic Spectrum of RRAGC-Associated Long-Olsen-Distelmaier Syndrome. · 6/10 · Diagnostics PMID:42927306 · Disease trajectories and lived experiences of patients with X-linked hypophosphatemia in Taiwan: a qualitative study. · 6/10 · Diagnostics PMID:42927036 · FaceKit: a Toolkit for Interpretable Facial Phenotyping, Synthetic Image Generation and Privacy Analysis in Rare Diseases. · 6/10 · Diagnostics
💡 UNSOLICITED FINDS
PMID:42927910 · Swedish Consensus Recommendation for Follow-Up After ICU Stay. · 7/10 · Other PMID:42927325 · Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study. · 7/10 · Treatment Innovation PMID:42927255 · Suicide mortality and suicide method trends in the Region of the Americas, 2015-2021: a population-based time-series analysis of progress toward a one-third reduction target. · 7/10 · Public Health PMID:42927195 · A Simple Clinical Index for Pretriage of Elevated Liver Stiffness in National Health and Nutrition Examination Survey 2017-2023. · 6/10 · Other
📊 TODAY'S BREAKDOWN
- By research category: Treatment Innovation 10 | Diagnostics 10 | Prevention 6 | Public Health 6 | Early Detection 6 | Genomics/Precision Medicine 4 | Other 2
- By evidence maturity: Exploratory 33 | Validated 11
- By watchlist topic:
- T1: Hematologic malignancies: 15 reviewed / 5 kept / highest 7
- T2: CBC-based diagnostics and machine learning in hematology: 1 reviewed / 1 kept / highest 5
- T3: Early cancer detection: 12 reviewed / 6 kept / highest 7
- T4: AI/ML in clinical diagnostics and imaging: 15 reviewed / 6 kept / highest 7
- T5: Precision oncology and genomic medicine: 12 reviewed / 5 kept / highest 6
- T6: Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 6 kept / highest 9
- T7: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 6 kept / highest 8
- T8: Aging, longevity, and population health: 11 reviewed / 5 kept / highest 7
- T9: Rare diseases with high unmet need: 7 reviewed / 5 kept / highest 7
- Sentinel: 10 reviewed / 4 kept / highest 7
- By source type: peer_reviewed 38 | preprint 6
- Topics with zero 8+ articles this run: T1: Hematologic malignancies; T2: CBC-based diagnostics and machine learning in hematology; T3: Early cancer detection; T4: AI/ML in clinical diagnostics and imaging; T5: Precision oncology and genomic medicine; T8: Aging, longevity, and population health; T9: Rare diseases with high unmet need
🔧 RUN NOTES
- Complete same-date UPSERT corpus regenerated; previously emitted articles were not excluded.
- All 104 unique selected PMIDs were independently reconciled in ESummary and EFetch; no endpoint records were missing.
- Per-topic review caps were 15 and the sentinel cap was 10. Topics above cap were truncated using PubMed pub-date ordering and are marked in Output A.
- T2 returned one primary-query candidate, so no fallback query was triggered.
- CRDT filtering is calendar-day based; 2026-10-25 records earlier than the timestamp boundary remain included by contract.
- No Telegram alerts were sent by this attempt; rerun alert deduplication is unchanged.